PT - JOURNAL ARTICLE AU - Henry S. Speno AU - Ruth Luthi-Carter AU - Wendy L. Macias AU - Stacey L. Valentine AU - Amit R. T. Joshi AU - Joseph T. Coyle TI - Site-Directed Mutagenesis of Predicted Active Site Residues in Glutamate Carboxypeptidase II AID - 10.1124/mol.55.1.179 DP - 1999 Jan 01 TA - Molecular Pharmacology PG - 179--185 VI - 55 IP - 1 4099 - http://molpharm.aspetjournals.org/content/55/1/179.short 4100 - http://molpharm.aspetjournals.org/content/55/1/179.full SO - Mol Pharmacol1999 Jan 01; 55 AB - Glutamate carboxypeptidase II (GCP II) catalyzes the extracellular hydrolysis of the neuromodulatorN-acetyl-aspartylglutamate toN-acetyl-aspartate and glutamate. GCP II also hydrolyzes γ-glutamyl bonds in folylpolyglutamate. The predicted amino acid sequence of GCP II displays similarities to aminopeptidases fromStreptomyces griseus and Vibrio proteolyticus, whose crystal structures have been determined. These aminopeptidases are cocatalytic zinc metallopeptidases belonging to the peptidase family M28. Specific zinc and substrate ligands have been proposed in GCP II based on the amino acid sequence alignment to these M28 family members. In the present study, site-directed mutagenesis has been used to test the assignment of these putative ligands in human GCP II. Substitutions to the five putative zinc ligands resulted in severely reduced enzyme activity, although mutant protein was expressed as demonstrated by immunoblot analysis. In addition, substitutions of amino acids near the putative zinc ligands have identified other specific residues important for enzyme structure and/or function. Substitutions to putative substrate ligands were less perturbing, and increases in K m were observed for substitutions that introduced a large charge perturbation (e.g., Lys to Glu). The results from substitutions at the proposed zinc and substrate ligands are consistent with the assignment of these residues and suggest that GCP II has a three-dimensional structure similar to other members of the peptidase family M28.